Clinical Trial Update: Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the performance of a bioresorbable scaffold during primary percutaneous intervention for STEMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Bioresorbable scaffold

Snippet

Sponsor: Haukeland University Hospital | Conditions: Acute ST Segment Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN